Regulatory Story
Go to market news section View chart   Print
Kainos Group plc   -  KNOS   

Board Change

Released 07:00 24-Jul-2019

RNS Number : 4599G
Kainos Group plc
24 July 2019

24 July 2019

Kainos Group plc

("Kainos" or the "Company") 

Kainos Board Change

Dr John Lillywhite has informed the Board of his intention to retire as Chairman and Director of Kainos Group plc at the conclusion of this year's Annual General Meeting on 26 September 2019 and will therefore not be standing for re-election as a Director.


John was instrumental in the creation of Kainos in 1986, a joint venture between ICL (now Fujitsu) and Queen's University Belfast. He was appointed Chairman in 1998, leading the company to IPO in July 2015 and has continued to serve as Chairman of Kainos as a public company since that time.


Commenting on today's announcement, Brendan Mooney, Kainos CEO said:


"Having worked closely with John over the past 20 years, I have seen first-hand the skills and experience that John has brought to his role as Chairman - both as a private company, and over the last four years as a public company. That skill is reflected in the growth of Kainos and the strong performance across the financial and people-based metrics of our business. As a company we are incredibly grateful for the leadership that he has demonstrated and the support that he has provided to Kainos and to the people that have worked closely with him."


John Lillywhite commented:


"It has been a great pleasure for me to be involved with Kainos since the very start, when it was just an idea, and to see it grow into the significant business that it is today. Throughout that period of time the company has been successful by delivering on our commitments - to our people, to our customers and to our shareholders. I continue to be excited by the future prospects for Kainos and I look forward to seeing the company achieve that potential in the years ahead."


The Board has initiated a search for John's successor.



For further information, please contact:


via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc

Patrick Robb / Sebastian Lawrence

+44 20 7597 5970

Canaccord Genuity

+44 20 7523 4606

Simon Bridges / Emma Gabriel

FTI Consulting LLP

+44 20 3727 1000

Matt Dixon / Harry Staight


About Kainos

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading boutique partner for Workday, Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records (EMR) is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.

Kainos has over 1,470 people across 12 offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Board Change - RNS